483Feb 25, 2022

483 Document: Mohnark Pharmaceuticals Inc

Lillian M. Colon-McKnight, FDA Investigator Joanne E. King, FDA Investigator

FDANews 483 Mohnark Pharmaceuticals Inc Feb 25 2022 top

Lillian M. Colon-McKnight FDA Investigator Joanne E. King FDA Investigator

On Feb 25, 2022, the FDA inspected Mohnark Pharmaceuticals Inc's Davie site. Explore the inspectional observations.